Therefore, this will be our future direction to investigate whether CCL2 promotes the selection of PCa stem/progenitor cells with inhibiting AR function or losing AR expression via an EMT-dependent pathway during ADT. The gene discussed is CCL2; the disease is posterior cortical atrophy.